Upgrade to SI Premium - Free Trial

JPMorgan Reiterates Overweight Rating on Novartis (NOVN:SW) (NVS)

July 22, 2026 2:48 AM
JPMorgan analyst Richard Vosser reiterated an ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Intl Ratings